Enoxaparin Concept

subject area of

• A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients  Journal Articles
• A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis  Journal Articles
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Journal Articles
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis  Journal Articles
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement  Journal Articles
• A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty  Journal Articles
• A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery  Journal Articles
• A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery  Journal Articles
• A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.  Journal Articles
• A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin  Journal Articles
• A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)  Journal Articles
• A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction  Journal Articles
• Abelacimab for Prevention of Venous Thromboembolism  Journal Articles
• American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19  Journal Articles
• Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors  Journal Articles
• Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery  Journal Articles
• Anticoagulants in acute coronary syndromes  Journal Articles
• Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Anti‐PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non‐drug risk factors and evidence for a stoichiometry‐based model of immunization  Journal Articles
• Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin  Journal Articles
• Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement  Journal Articles
• Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients  Journal Articles
• Apixaban versus Enoxaparin in Medically Ill Patients  Journal Articles
• Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial  Journal Articles
• Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial  Journal Articles
• Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery  Journal Articles
• Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials  Journal Articles
• BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study  Journal Articles
• Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty  Journal Articles
• Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT)  Journal Articles
• Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin  Journal Articles
• Can we differentiate the low-molecular-weight heparins?  Journal Articles
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Journal Articles
• Ciraparantag for enoxaparin reversal: Adding to the evidence  Journal Articles
• Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo  Journal Articles
• Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin  Journal Articles
• Clinical trials of deep vein thrombosis prophylaxis in medical patients  Journal Articles
• Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist  Journal Articles
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conferences
• Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome  Journal Articles
• Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy  Journal Articles
• Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes  Journal Articles
• Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins  Journal Articles
• Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial  Journal Articles
• Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study  Journal Articles
• Cost prediction models for the comparison of two groups  Journal Articles
• Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.  Journal Articles
• Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis  Journal Articles
• Dabigatran etexilate for prevention of venous thromboembolism  Journal Articles
• Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer  Journal Articles
• Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)  Journal Articles
• Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes  Journal Articles
• Differences in the safety profiles of two low-molecular-weight heparins  Journal Articles
• Dose Capping Enoxaparin Is Unjustified and Denies Patients With Acute Coronary Syndromes a Potentially Effective Treatment  Journal Articles
• Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome  Journal Articles
• ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.  Journal Articles
• Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy  Journal Articles
• Economic Evaluation of the MEDENOX Trial: A Canadian Perspective  Journal Articles
• Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review  Journal Articles
• Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction].  Journal Articles
• Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial  Journal Articles
• Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty  Journal Articles
• Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis  Journal Articles
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines  Journal Articles
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention  Journal Articles
• Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19  Journal Articles
• Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment  Journal Articles
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction  Journal Articles
• Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years  Journal Articles
• Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty  Journal Articles
• Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates  Journal Articles
• Enoxaparin in the Treatment of Deep Vein Thrombosis With or Without Pulmonary Embolism  Journal Articles
• Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery  Journal Articles
• Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction  Journal Articles
• Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization.  Journal Articles
• Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility  Journal Articles
• Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study  Journal Articles
• Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis  Journal Articles
• Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism  Journal Articles
• Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates  Journal Articles
• Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors  Journal Articles
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery  Journal Articles
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery  Journal Articles
• Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur  Journal Articles
• Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk  Journal Articles
• Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6  Journal Articles
• Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial  Journal Articles
• Fondaparinux versus enoxaparin for prevention of venous thromboembolism  Journal Articles
• Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle>  Journal Articles
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin  Journal Articles
• Idrabiotaparinux treatment for venous thromboembolism  Journal Articles
• Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients  Journal Articles
• Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction  Journal Articles
• Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes  Journal Articles
• In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation  Journal Articles
• Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes  Journal Articles
• Less menorrhagia for women with VTE  Journal Articles
• Letter to the editor  Journal Articles
• Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism  Journal Articles
• Low molecular weight heparins in the treatment of unstable angina.  Journal Articles
• Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction  Journal Articles
• Low-Molecular-Weight Heparins  Journal Articles
• Low-molecular-weight heparins - reply  Journal Articles
• Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.  Journal Articles
• Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial  Conferences
• Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting  Journal Articles
• Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction: Challenging Cases and Practical Algorithms  Journal Articles
• Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.  Journal Articles
• Management of unstable angina and myocardial infarction  Journal Articles
• Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides  Journal Articles
• Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo  Journal Articles
• Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency  Journal Articles
• Milvexian for the Prevention of Venous Thromboembolism  Journal Articles
• Minimizing costs for treating deep vein thrombosis: the role for fondaparinux  Journal Articles
• Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound  Journal Articles
• Optimizing Prophylaxis of Venous Thromboembolism  Journal Articles
• Oral Apixaban for the Treatment of Acute Venous Thromboembolism  Journal Articles
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Journal Articles
• Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism  Journal Articles
• Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial  Journal Articles
• Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement  Journal Articles
• Overview of the clinical results of pentasaccharide in major orthopedic surgery.  Journal Articles
• Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial  Journal Articles
• Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison  Journal Articles
• Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery  Journal Articles
• Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.  Journal Articles
• Prevention of venous thromboembolism in medical patients with enoxaparin  Journal Articles
• Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)  Journal Articles
• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study  Journal Articles
• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.  Journal Articles
• Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes  Journal Articles
• Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin  Journal Articles
• Review of enoxaparin and its clinical applications in venous and arterial thromboembolism  Journal Articles
• Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness  Journal Articles
• Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro  Journal Articles
• Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty  Journal Articles
• Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies  Journal Articles
• Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty  Journal Articles
• Rivaroxaban versus enoxaparin after total knee arthroplasty  Journal Articles
• Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial  Journal Articles
• SR123781A: A New Once-Daily Synthetic Oligosaccharide Anticoagulant for Thromboprophylaxis After Total Hip Replacement Surgery  Journal Articles
• Selective factor Xa inhibition for thromboprophylaxis  Journal Articles
• Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE  Journal Articles
• Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review  Journal Articles
• Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points  Journal Articles
• The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes  Journal Articles
• The Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty  Journal Articles
• The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle>  Conferences
• The United States Food and Drugs Administration Approves a Generic Enoxaparin  Journal Articles
• The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients  Journal Articles
• The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery  Journal Articles
• The effects of rivaroxaban on the complications of surgery after total hip or knee replacement  Journal Articles
• The use of low molecular weight heparin in pediatric patients: A prospective cohort study  Journal Articles
• The use of low molecular weight heparins in pediatrics: Two cases that highlight potential risks to patient safety  Journal Articles
• Therapy of unstable angina with the low molecular weight heparins  Journal Articles
• Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial  Journal Articles
• Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ?  Journal Articles
• Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials  Journal Articles
• Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial  Journal Articles
• Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart Palliation  Journal Articles
• To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections  Journal Articles
• Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial  Journal Articles
• Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study  Journal Articles
• Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children  Journal Articles
• Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients  Journal Articles
• Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study  Journal Articles
• Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.  Journal Articles
• Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?  Journal Articles
• XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden.  Conferences